Next Article in Journal
Factor XIa Inhibitors as a Novel Anticoagulation Target: Recent Clinical Research Advances
Next Article in Special Issue
In Vitro and In Silico Evaluation of Antiproliferative Activity of New Isoxazolidine Derivatives Targeting EGFR: Design, Synthesis, Cell Cycle Analysis, and Apoptotic Inducers
Previous Article in Journal
Binary Polymeric Surfactant Mixtures for the Development of Novel Loteprednol Etabonate Nanomicellar Eyedrops
Previous Article in Special Issue
7-Chloroquinolinehydrazones as First-in-Class Anticancer Experimental Drugs in the NCI-60 Screen among Different Investigated Series of Aryl, Quinoline, Pyridine, Benzothiazole and Imidazolehydrazones
 
 
Article

Article Versions Notes

Pharmaceuticals 2023, 16(6), 865; https://doi.org/10.3390/ph16060865
Action Date Notes Link
article pdf uploaded. 11 June 2023 09:11 CEST Version of Record https://www.mdpi.com/1424-8247/16/6/865/pdf-vor
article supplementary file uploaded. 11 June 2023 09:11 CEST - https://www.mdpi.com/1424-8247/16/6/865#supplementary
article pdf uploaded. 11 June 2023 09:47 CEST Updated version of record https://www.mdpi.com/1424-8247/16/6/865/pdf-vor
article xml file uploaded 12 June 2023 07:43 CEST Original file -
article xml uploaded. 12 June 2023 07:43 CEST Update -
article pdf uploaded. 12 June 2023 07:43 CEST Updated version of record https://www.mdpi.com/1424-8247/16/6/865/pdf-vor
article html file updated 12 June 2023 07:44 CEST Original file -
article xml file uploaded 15 June 2023 04:28 CEST Update -
article xml uploaded. 15 June 2023 04:28 CEST Update https://www.mdpi.com/1424-8247/16/6/865/xml
article pdf uploaded. 15 June 2023 04:29 CEST Updated version of record https://www.mdpi.com/1424-8247/16/6/865/pdf
article html file updated 15 June 2023 04:30 CEST Update -
article html file updated 20 June 2023 21:50 CEST Update https://www.mdpi.com/1424-8247/16/6/865/html
Back to TopTop